Studies on the use of a novel affinity matrix, sepharose amine-succinyl-amine haloperidol hemisuccinate, ASA-HHS, for purification of canine dopamine (D2) receptor.
Haloperidol Hemisuccinate (HHS) was synthesized specifically as a ligand for an affinity chromatography matrix. The affinity chromatography matrix, ASA-HHS was developed which had high affinity and capacity for dopamine D2 receptors in solubilized canine striatal preparations. ASA-HHS also demonstrated nonspecific interaction with the D2 receptor. Two fractions, which bound 3H-spiroperidol specifically, with similar one dimensional SDS-PAGE patterns could be eluted successfully with 20 microM haloperidol in only 30% of the runs. Both fractions represented 300-400 fold purification. Two dimensional IEF-PAGE analysis of one of the fractions demonstrated coelution of beta and gamma actin, alpha and beta tubulin with the 3H-spiroperidol binding sites. The pattern of the proteins eluted from ASA-HHS and the inconsistent recovery of active D2 receptors are discussed.